KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
KBIO was delisted on the 16th of December, 2015.
24 hedge funds and large institutions have $4.01M invested in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in 2015 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 16 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
33% less funds holding
Funds holding: 36 → 24 (-12)
75% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 16
86% less capital invested
Capital invested by funds: $28.7M → $4.01M (-$24.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OPPM
Opus Point Partners Management
New York
|
+$112K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$61.3K |
| 3 |
Renaissance Technologies
New York
|
+$47.8K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$38.8K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$35.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$3.96M |
| 2 |
First Eagle Investment Management
New York
|
-$3.02M |
| 3 |
UBS AM
Chicago,
Illinois
|
-$2.79M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.73M |
| 5 |
SIM
SSI Investment Management
Los Angeles,
California
|
-$612K |
KBIO Hedge Fund Activity: Q1 2015 in Review
24 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) for Q1 2015, worth a combined $4.01M — down 86% from $28.7M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of KBIO and 4 opened new positions — a net loss of 12 holders — while 6 trimmed existing stakes and 6 added.
The largest buyer was Opus Point Partners Management, adding an estimated $112K. The largest seller was Deerfield Management, exiting entirely with an estimated $3.96M sold.
- 24 institutional investors held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) as of Q1 2015, down from 36 in Q4 2014.
- Funds reported $4.01M of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) stock for Q1 2015, down 86% quarter-over-quarter.
- 4 funds opened new KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) positions in Q1 2015 and 16 closed out, a net change of -12 holders.
- The largest KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) buyer in Q1 2015 was Opus Point Partners Management, an estimated $112K added.
- The largest KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) seller in Q1 2015 was Deerfield Management, an estimated $3.96M sold.
Based on aggregated 13F filings for Q1 2015.